Search Results 331-340 of 15141 for Humira

  1. Overview - Enteric Neuroscience Program - Mayo Clinic Research

    Chronic constipation. Clostridium difficile infection. Crohn's disease. Diabetic gastroparesis. Enteric neuropathies. Functional dyspepsia. Irritable bowel ...

  2. Lubiprostone (oral route) - Mayo Clinic

    Lubiprostone is also used to treat irritable bowel syndrome (IBS) in women who have constipation as the main symptom. This medicine is available only with your ...

  3. A Study to Assess Outcome of Hospitalization for Cirrhosis Patients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Anesthetic, local (topical application route) - Mayo Clinic

    This medicine belongs to a group of medicines known as topical local anesthetics. Topical anesthetics are used to relieve pain and itching caused by conditions ...

  5. Pediatrics Clinical Trials - Medical Professionals

    Rochester, Minn. The purpose of this Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing ...

  6. Improving the Quality of Care for Adults with Inflammatory Bowel Disease - Mayo Clinic

    The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients and ...

  7. Brimonidine and brinzolamide (ophthalmic route) - Mayo Clinic

    This medicine can help you keep your sight by reducing the pressure in your eye and stopping eye pain. This medicine is available only with your doctor's ...

  8. A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma - Mayo Clinic

    The purpose of this study is to investigate the effect of benralizumab on the rate of asthma exacerbations, patient reported quality of life and lung function ...

  9. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma - Mayo Clinic

    Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant ...

  10. Radicava® (Edaravone) Biomarker Study in Participants with Amyotrophic Lateral Sclerosis - Mayo Clinic

    However, as observed in prior clinical trials, ALS presentation and progression is extremely heterogeneous among patients. There is therefore an imperious need ...